Animal Anti Infective Medicine Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : May 2022 Pages : 180 Category: Pharma & Healthcare Report Code : HC0511352
Animal Anti Infective Medicine Market by Type (External Use, Internal Use) Application (Livestock, Pets, Marine Animal) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Animal Anti Infective Medicine Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. For the Animal Pain Relief, FDA has approved several nonsteroidal anti-inflammatory drugs for dogs to control pain and inflammation associated with osteoarthritis; and to control pain and inflammation after soft tissue and orthopedic surgery.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
-
- Boehringer Ingelheim
- Zoetis
- Merck
- Elanco
- Bayer
- Virbac
- Ceva Sante Animale
- Vetoquinol
- Bimeda Animal Health
- Chanelle
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Animal Anti Infective Medicine Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o External Use
o Internal Use
· Animal Anti Infective Medicine Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Livestock
o Pets
o Marine Animal
· Animal Anti Infective Medicine Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Boehringer Ingelheim
o Zoetis
o Merck
o Elanco
o Bayer
o Virbac
o Ceva Sante Animale
o Vetoquinol
o Bimeda Animal Health
o Chanelle
· Animal Anti Infective Medicine Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Submarine Cables Market, By Country
o U.S. Submarine Cables Market
o Canada Submarine Cables Market
o Mexico Submarine Cables Market
o Europe
§ Europe Submarine Cables Market, By Country
o Germany Submarine Cables Market
o UK Submarine Cables Market
o France Submarine Cables Market
o Russia Submarine Cables Market
o Italy Submarine Cables Market
o Rest of Europe Submarine Cables Market
o Asia-Pacific
§ Asia-Pacific Submarine Cables Market, By Country
o China Submarine Cables Market
o Japan Submarine Cables Market
o South Korea Submarine Cables Market
o India Submarine Cables Market
o Southeast Asia Submarine Cables Market
o Rest of Asia-Pacific Submarine Cables Market
o South America
§ South America Submarine Cables Market
o Brazil Submarine Cables Market
o Argentina Submarine Cables Market
o Columbia Submarine Cables Market
o Rest of South America Submarine Cables Market
o Middle East and Africa
§ Middle East and Africa Submarine Cables Market
o Saudi Arabia Submarine Cables Market
o UAE Submarine Cables Market
o Egypt Submarine Cables Market
o Nigeria Submarine Cables Market
o South Africa Submarine Cables Market
o Rest of MEA Submarine Cables Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Animal Anti Infective Medicine Market, By Type
5.1. Introduction
5.2. Global Animal Anti Infective Medicine Revenue and Market Share by Type (2017-2021)
5.2.1. Global Animal Anti Infective Medicine Revenue and Revenue Share by Type (2017-2021)
5.3. External Use
5.3.1. Global External Use Revenue and Growth Rate (2017-2021)
5.4. Internal Use
5.4.1. Global Internal Use Revenue and Growth Rate (2017-2021)
6. Animal Anti Infective Medicine Market, By Applications
6.1. Introduction
6.2. Global Animal Anti Infective Medicine Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Animal Anti Infective Medicine Revenue and Revenue Share by Applications (2017-2021)
6.3. Livestock
6.3.1. Global Livestock Revenue and Growth Rate (2017-2021)
6.4. Pets
6.4.1. Global Pets Revenue and Growth Rate (2017-2021)
6.5. Marine Animal
6.5.1. Global Marine Animal Revenue and Growth Rate (2017-2021)
7. Animal Anti Infective Medicine Market, By Region
7.1. Introduction
7.2. Global Animal Anti Infective Medicine Revenue and Market Share by Regions
7.2.1. Global Animal Anti Infective Medicine Revenue by Regions (2017-2021)
7.3. North America Animal Anti Infective Medicine by Countries
7.3.1. North America Animal Anti Infective Medicine Revenue and Growth Rate (2017-2021)
7.3.2. North America Animal Anti Infective Medicine Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Animal Anti Infective Medicine by Countries
7.4.1. Europe Animal Anti Infective Medicine Revenue and Growth Rate (2017-2021)
7.4.2. Europe Animal Anti Infective Medicine Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Animal Anti Infective Medicine by Countries
7.5.1. Asia-Pacific Animal Anti Infective Medicine Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Animal Anti Infective Medicine Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Animal Anti Infective Medicine by Countries
7.6.1. South America Animal Anti Infective Medicine Revenue and Growth Rate (2017-2021)
7.6.2. South America Animal Anti Infective Medicine Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Animal Anti Infective Medicine by Countries
7.7.1. Middle East and Africa Animal Anti Infective Medicine Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Animal Anti Infective Medicine Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Boehringer Ingelheim
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Zoetis
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Merck
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Elanco
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Bayer
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Virbac
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Ceva Sante Animale
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Vetoquinol
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Bimeda Animal Health
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Chanelle
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Animal Anti Infective Medicine Market Forecast (2022-2027)
9.1. Global Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Animal Anti Infective Medicine Market Forecast by Regions (2022-2027)
9.2.1. North America Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.1.1. United States Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.1.2. Canada Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.1.3. Mexico Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.2. Europe Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.2.1. Germany Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.2.2. France Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.2.3. UK Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.2.4. Russia Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.2.5. Italy Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.3. Asia-Pacific Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.3.1. China Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.3.2. Japan Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.3.3. Korea Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.3.4. India Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.4. South America Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.4.1. Brazil Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.4.2. Argentina Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.4.3. Columbia Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.4.4. Rest of South America Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.5. Middle East and Africa Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.5.3. Egypt Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.5.4. Nigeria Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.5.5. South Africa Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.5.6. Turkey Animal Anti Infective Medicine Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Animal Anti Infective Medicine Market Forecast (2022-2027)
9.3. Animal Anti Infective Medicine Market Forecast by Type (2022-2027)
9.3.1. Animal Anti Infective Medicine Forecast by Type (2022-2027)
9.3.2. Animal Anti Infective Medicine Market Share Forecast by Type (2022-2027)
9.4. Animal Anti Infective Medicine Market Forecast by Applications (2022-2027)
9.4.1. Animal Anti Infective Medicine Forecast by Applications (2022-2027)
9.4.2. Animal Anti Infective Medicine Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Animal Anti Infective Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Animal Anti Infective Medicine Revenue and Revenue Share by Type (2017-2019)
Figure Global External Use Revenue and Growth Rate (2017-2019)
Figure Global Internal Use Revenue and Growth Rate (2017-2019)
Table Global Animal Anti Infective Medicine Revenue and Revenue Share by Applications (2017-2019)
Figure Global Livestock Revenue and Growth Rate (2017-2019)
Figure Global Pets Revenue and Growth Rate (2017-2019)
Figure Global Marine Animal Revenue and Growth Rate (2017-2019)
Table Global Animal Anti Infective Medicine Revenue by Regions (2017-2019)
Figure North America Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure North America Animal Anti Infective Medicine Revenue and Growth Rate (2017-2019)
Figure North America Animal Anti Infective Medicine by Countries (2017-2019)
Figure North America Animal Anti Infective Medicine Revenue (Million USD) by Countries (2017-2019)
Figure United States Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure United States Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Canada Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Mexico Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Europe Animal Anti Infective Medicine Revenue and Growth Rate (2017-2019)
Figure Europe Animal Anti Infective Medicine by Countries (2017-2019)
Figure Europe Animal Anti Infective Medicine Revenue (Million USD) by Countries (2017-2019)
Figure Germany Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Germany Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure France Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure UK Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Russia Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Italy Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Rest of Europe Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Asia-Pacific Animal Anti Infective Medicine Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Animal Anti Infective Medicine by Countries (2017-2019)
Figure Asia-Pacific Animal Anti Infective Medicine Revenue (Million USD) by Countries (2017-2019)
Figure China Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure China Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Japan Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Korea Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure India Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Southeast Asia Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure South America Animal Anti Infective Medicine Revenue and Growth Rate (2017-2019)
Figure South America Animal Anti Infective Medicine by Countries (2017-2019)
Figure South America Animal Anti Infective Medicine Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Brazil Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Argentina Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Columbia Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Rest of South America Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Middle East and Africa Animal Anti Infective Medicine Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Animal Anti Infective Medicine by Countries (2017-2019)
Figure Middle East and Africa Animal Anti Infective Medicine Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Saudi Arabia Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure United Arab Emirates Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Egypt Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Nigeria Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure South Africa Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Turkey Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Animal Anti Infective Medicine Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Table Boehringer Ingelheim Animal Anti Infective Medicine Financial Overview
Table Zoetis Animal Anti Infective Medicine Financial Overview
Table Merck Animal Anti Infective Medicine Financial Overview
Table Elanco Animal Anti Infective Medicine Financial Overview
Table Bayer Animal Anti Infective Medicine Financial Overview
Table Virbac Animal Anti Infective Medicine Financial Overview
Table Ceva Sante Animale Animal Anti Infective Medicine Financial Overview
Table Vetoquinol Animal Anti Infective Medicine Financial Overview
Table Bimeda Animal Health Animal Anti Infective Medicine Financial Overview
Table Chanelle Animal Anti Infective Medicine Financial Overview
Figure Global Animal Anti Infective Medicine Revenue (Millions USD) and Growth Rate (2019-2027)
Table Animal Anti Infective Medicine Market Forecast by Regions (2019-2027)
Figure North America Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure United States Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Canada Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Mexico Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Europe Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Germany Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure France Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure UK Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Russia Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Italy Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Rest of Europe Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Asia-Pacific Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure China Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Japan Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Korea Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure India Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Southeast Asia Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure South America Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Brazil Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Argentina Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Columbia Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Rest of South America Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Middle East and Africa Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Saudi Arabia Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure United Arab Emirates Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Egypt Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Nigeria Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure South Africa Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Turkey Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Animal Anti Infective Medicine Market Forecast (2019-2027)
Figure Global Animal Anti Infective Medicine Forecast by Type (2019-2027)
Figure Global Animal Anti Infective Medicine Market Share Forecast by Type (2019-2027)
Figure Global Animal Anti Infective Medicine Forecast by Type (2019-2027)
Figure Global Animal Anti Infective Medicine Forecast by Applications (2019-2027)
Figure Global Animal Anti Infective Medicine Market Share Forecast by Applications (2019-2027)
Figure Global Animal Anti Infective Medicine Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|